Lipid Mediators of Inflammation and Resolution in Individuals with Tuberculosis and Tuberculosis-Diabetes

Individuals with concurrent tuberculosis (TB) and Type 2 diabetes (DM) have a higher risk of adverse outcomes. To better understand potential immunological differences, we utilized a comprehensive panel to characterize pro-inflammatory and pro-resolving (i.e., mediators involved in the resolution of...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Prostaglandins Other Lipid Mediat
Auteurs principaux: Shivakoti, Rupak, Dalli, Jesmond, Kadam, Dileep, Gaikwad, Sanjay, Barthwal, Madhusudan, Colas, Romain A., Mazzacuva, Francesca, Lokhande, Rahul, Dharmshale, Sujata, Bharadwaj, Renu, Kagal, Anju, Pradhan, Neeta, Deshmukh, Sona, Atre, Sachin, Sahasrabudhe, Tushar, Kakrani, Arjun, Kulkarni, Vandana, Raskar, Swapnil, Suryavanshi, Nishi, Chon, Sandy, Gupte, Akshay, Gupta, Amita, Gupte, Nikhil, Arriaga, María B., Fukutani, Kiyoshi F., Andrade, Bruno B., Golub, Jonathan E., Mave, Vidya
Format: Artigo
Langue:Inglês
Publié: 2019
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7067657/
https://ncbi.nlm.nih.gov/pubmed/31726221
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.prostaglandins.2019.106398
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires